Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-11-21

Clinical Trial Update: Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After a Recent Myocardial Infarction [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating testosterone replacement to improve exercise capacity in hypogonadal men after acute myocardial infarction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

Sponsor: Texas Tech University Health Sciences Center | Conditions: Hypogonadism, Acute Myocardial Infarction: Rehabilitation Phase | Phase 2, Phase 3 | Status: WITHDRAWN